Literature DB >> 1504447

The pathophysiological role and therapeutic implications of platelet activating factor in diseases of aging.

C Kroegel1, C Kortsik, N Kroegel, H Matthys.   

Abstract

Platelet activating factor (PAF) is a unique phosphoglyceride which possesses many potent biological activities relevant for the pathogenesis of diseases of the elderly. PAF is generated and released by numerous cell types and tissues and is rapidly metabolised through a well defined metabolic cycle. Its biological actions are mediated via direct and indirect stimulatory effects on target cells and tissues. The current knowledge of PAF and its role in cardiovascular disease, thromboembolism, cerebral ischaemia and neurodegenerative disorders are discussed in detail. It is likely, that in future, a better understanding of the pathophysiological and physiological roles of PAF will provide new strategies for the treatment of human diseases of aging.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504447     DOI: 10.2165/00002512-199202040-00007

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  66 in total

1.  Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells.

Authors:  T A Brock; M A Gimbrone
Journal:  Am J Physiol       Date:  1986-06

2.  Antigen induced histamine release from platelets of rabbits producing homologous PCA antibody.

Authors:  J F Barbaro; N J Zvaifler
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

3.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

Review 4.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

5.  Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock.

Authors:  D L Birkle; P Kurian; P Braquet; N G Bazan
Journal:  J Neurochem       Date:  1988-12       Impact factor: 5.372

6.  Stimulation of degranulation from human eosinophils by platelet-activating factor.

Authors:  C Kroegel; T Yukawa; G Dent; P Venge; K F Chung; P J Barnes
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

7.  Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.

Authors:  D M Humphrey; L M McManus; D J Hanahan; R N Pinckard
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

8.  Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.

Authors:  D A Handley; M L Lee; R N Saunders
Journal:  Thromb Haemost       Date:  1985-12-17       Impact factor: 5.249

9.  Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles.

Authors:  J Tamargo; T Tejerina; C Delgado; S Barrigon
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

10.  Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia.

Authors:  I Leprán; A M Lefer
Journal:  Basic Res Cardiol       Date:  1985 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.